Evidence map›Paper›PMID 30787928›Full record

ArticleFrontiers in immunology2019

Joudy Alameddine, Emmanuelle Godefroy, Loukas Papargyris, Guillaume Sarrabayrouse, Julie Tabiasco, Chantal Bridonneau, Karina Yazdanbakhsh, Harry Sokol, Frédéric Altare, Francine Jotereau

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 1 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 1 synthesis or guideline pooled it, 115 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Recent advances in the positive role ofFrontiers in immunology · 2026
    Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 3 countries.

Joudy AlameddineCRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.
Emmanuelle GodefroyCRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.
Loukas PapargyrisCRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France.
Guillaume SarrabayrouseVall d'Hebron Institute of Research, Barcelona, Spain.
Julie TabiascoCRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France.
Chantal BridonneauMicalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France.
Karina YazdanbakhshNew York Blood Center, LFK Research Institute, New York, NY, United States.
Harry SokolMicalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France.
Frédéric AltareCRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.
Francine JotereauCRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.
Université d'Angers · FRNantes Université · FRAssistance Publique – Hôpitaux de Paris · FRInserm · FRNew York Blood Center · USUniversité Paris-Saclay · FRVall d'Hebron Institut de Recerca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human colonic mucosa contains regulatory type 1-like (Tr1-like, i.e., IL-10-secreting and Foxp3-negative) T cells specific for the gut

Indexed as

Faecalibacterium prausnitziiApyraseClostridiumColonCytokinesDendritic CellsHumansIndoleamine-Pyrrole 2,3,-DioxygenaseMAP Kinase Signaling SystemT-Lymphocytes, RegulatoryToll-Like Receptor 2Toll-Like Receptor 6ApyraseCytokinesENTPD1 protein, humanIDO1 protein, humanIndoleamine-Pyrrole 2,3,-DioxygenaseTLR2 protein, humanTLR6 protein, humanToll-Like Receptor 2Toll-Like Receptor 6CD39colon homeostasisdendritic cellsgut microbiotaIDO-1JNKTLR2/6Tr1-like Treg

Identifiers

PMID30787928
PMCPMC6373781
OpenAlexW2911695870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.